Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 3-12 , February 2009

What have we learnt from early rheumatoid arthritis cohorts?

  • Adam Young, MD (Consultant Rheumatologist)

      Affiliations

    • Corresponding Author InformationTel.: +44 1727 897362; Fax: +44 01727 897042.

References 

  1. Suarez-Almazor ME. In quest of the Holy Grail: efficacy versus effectiveness. J Rheumatol. 2002;45:1–6
  2. Furst DE. Observational cohort studies and well controlled clinical trials – we need them both. J Rheumatol. 2004;31:1476–1477
  3. Felson D, Anderson J, Meenan R. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis: results of two meta-analyses. Arthritis Rheum. 1990;33:1449–1461
  4. Wolfe F, Hawley D, Cathey MA. Termination of slow acting anti rheumatic drugs in RA: a 14 year prospective evaluation of 1017 starts. J Rheumatol. 1990;17:994–1002
  5. Porter DR, McInnes I, Hunter J, Capell HA. Outcome of second-line therapy in rheumatoid arthritis. Ann Rheum Dis. 1995;53:812–815
  6. Barton S. Which clinical studies provide best evidence?. Br Med J. 2000;321:255–256
  7. Choi HK. Outcomes research in rheumatology. Rheum Dis Clin North Am. 2004;30:4
  8. Wolfe F. Recommended reporting requirements for long-term observational studies in RA. J Rheumatology. 1999;26:484–489
  9. Jacoby RK, Jayson MI, Cosh JA. Onset, early stages, and prognosis of RA: a clinical study of 100 patients with 11 year follow up. Br Med J. 1973;2:96–100
  10. Fleming A, Crown J, Corbett M. Incidence of joint involvement in early rheumatoid arthritis. Rheumatol Rehabil. 1976;15:92–96
  11. Brooks A, Corbett M. Radiographic changes in early rheumatoid arthritis. Ann Rheum Dis. 1977;36:71–73
  12. Arnett FC, Edworthy SM, Bloch DA, et al. The ARA 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324
  13. Fries J, Spitz P, Young D. Dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol. 1982;9:789–793
  14. Ware J. Measuring patients' views: the optimum outcome measure. Br Med J. 1993;306:1429–1430
  15. van der Heijde DMFM, van't Hof MA, van Riel PLCM, et al. Judging disease activity in clinical practice in RA. First step in the development of a disease activity score. Ann Rheum Dis. 1990;49:916–920
  16. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of RA: a prospective follow-up study of a Swedish cohort. Br J Rheumatol. 1996;35:1106–1115
  17. van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, et al. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. Br J Rheumatol. 1992;8:519–526
  18. Brennan P, Harrison B, Barrett E, et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. Br Med J. 1996;24(313):471–476
  19. Plant MJ, Jones PW, Sklatvala J, et al. Patterns of radiological progression in early rheumatoid arthritis-results of an 8 year prospective study. J Rheumatol. 1998;25:417–426
  20. van der Heijde DMFM, van Leeuwen A, van Riel PLCM, et al. Biannual radiographic assessments of hands and feet in a three-year prospective follow-up of patients with early rheumatoid arthritis. Arthritis Rheum. 1992;35:26–33
  21. van Zeben D, Hazes J, Zwinderman A, et al. Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol. 1993;20:1288–1296
  22. Dixey J, Solymossy C, Jones P, et al. Structural damage as measured by radiographs accelerates between years two and three in early rheumatoid arthritis. Rheumatology. 2004;43(Suppl. 2):344
  23. Wolfe F, Sharp JT. Radiographic outcome of recent-onset RA: a 19-year study of radiographic progression. Arthritis Rheum. 1998;41:1571–1582
  24. Ostergaard M, Hansen M, Crabbe J, et al. New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier. Arthritis Rheum. 2003;48:128–131
  25. Kuper HH, van Leeuwen MA, van Riel PLCM, et al. Radiographic damage in large joints in early rheumatoid arthritis: relationship with radiographic damage in hands and feet, disease activity, and physical disability. Br J Rheumatol. 1997;36:855–860
  26. Winfield J, Young A, Williams P, Corbett M. A prospective study of the radiological changes of hands, feet and cervical spine in adult Rheumatoid disease. Ann Rheum Dis. 1983;42:613–618
  27. Young A, Corbett M, Winfield J, et al. A prognostic index for erosive changes in the hands, feet, and cervical spines in early Rheumatoid Arthritis. Br J Rheumatol. 1988;27:94–101
  28. Dixey J, Solymossy C, Young A. Is it possible to predict radiological damage in early RA? A report on occurrence, progression and prognostic factors for radiological erosions over first 3 years in 860 patients from early RA study (ERAS). J Rheumatol. 2004;31(Suppl. 69):48–54
  29. Combe B, Dougados M, Goupile P, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis. Arthritis Rheum. 2000;44:1736–1743
  30. Mayer O, Labarre C, Dougados M, et al. Anti-CCP assays in early RA for predicting 5 yr radiographic damage. Ann Rheum Dis. 2003;62:120–126
  31. Syversen SW, Gaardner PI, Goll GL, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with RA: results from 1 10 yr longitudinal study. Ann Rheum Dis. 2008;67:212–217
  32. Liang M, Larson M, Cullen K, Schwartz J. Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum. 1985;28:542–547
  33. Fries JF. New instruments for assessing disability: not quite ready for prime time. Arthritis Rheum. 2004;50:3064–3067
  34. Young A, Dixey J, Kulinskaya K, et al. Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from ERAS. Ann Rheum Dis. 2002;61:335–340
  35. de Croon EM, Sluiter JK, Nijssen TF, et al. Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2004;63:1362–1367
  36. Pincus T, Brooks RA, Callahan LF. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures. Ann Int Med. 1994;120:26–34
  37. Carr A, Thompson P, Young A. Do health status measures (HSM) have a role in rheumatology? A survey of the use of and attitudes towards health status measures in the UK. Arthritis Rheum. 1996;ACR abstracts S261
  38. Eberhardt KB, Fex E. Functional impairment and disability in early rheumatoid arthritis - development over 5 years. J Rheumatol. 1995;22:1037–1042
  39. Young A, Dixey J, Cox N, et al. How does functional disability in early rheumatoid arthritis affect patients and their lives? Results of 5 yr follow up in 781 patients from the Early RA Study (ERAS). Rheumatology (Oxford). 2000;39:603–611
  40. Wiles NJ, Dunn G, Barrett EM, et al. One year follow up variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline. J Rheumatol. 2000;27:2360–2366
  41. Combe B, Cantagrel A, Goupille P, et al. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. J Rheumatol. 2003;30:2344–2349
  42. Young A, Wilkinson P, Talamo J, et al. Socio-economic factors in the presentation and outcome of early rheumatoid arthritis. Lessons for the health service?. Ann Rheum Dis. 2000;59:794–799
  43. Young A, van der Heijde DFM. Can we predict aggressive disease?. Clin Rheumatol. 1997;11:27–48
  44. Bansback NJ, Young A, Brennan A, Dixey J. A prognostic model for functional outcome in early rheumatoid arthritis. J Rheumatol. 2006;33:1503–1510
  45. Fex E, Larsson B-M, Nived K, Eberhardt K. Effect of RA on work status and social and leisure time activities in patients followed 8 years from onset. J Rheumatol. 1998;25:44–50
  46. Mau W, Bornmann M, Weber H, et al. Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using recpam. Br J Rheumatol. 1996;35:652–659
  47. Barrett EM, Scott DGI, Wiles NJ, Symmons DPM. The impact of rheumatoid arthritis on employment status in the early years of disease: a UK community-based study. Rheumatology (Oxford). 2000;39:1403–1409
  48. James D, Young A, Kulinskaya E, et al. Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1029 patients followed for 5 years. Rheumatology (Oxford). 2004;43:369–376
  49. Eberhardt KB, Fex E, Johnson U, Wollheim FA. Association of HLA-DRB and DQB genes with two and five year outcome in rheumatoid arthritis. Ann Rheum Dis. 1996;55:34–39
  50. Wolfe F, Zwillich S. The long-term outcomes of rheumatoid arthritis. Arthritis Rheum. 1998;41:1072–1082
  51. Symmons DPM. Mortality in rheumatoid arthritis. Br J Rheumatol. 1988;44(Suppl. 1):44–54
  52. Wolfe F, Mitchell DM, Sibley PW, Young DY. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481–494
  53. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in Rheumatoid Arthritis. Arthritis Rheum. 2003;48:54–58
  54. Riise T, Jacobsen BK, Gran JT, et al. Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin Rheumatol. 2001;20:123–127
  55. Corbett M, Young A, Dalton D, et al. Factors predicting death, survival and functional outcome in a prospective study of early Rheumatoid Disease over fifteen years. Br J Rheumatol. 1993;32:717–723
  56. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease in the 1980s. Ann Rheum Dis. 1999;58:11–14
  57. Kroot EJA, van Leuuwen MA, van Rijswijk MH, et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years follow-up from disease onset. Ann Rheum Dis. 2000;59:954–958
  58. Young A, Koduri G, Batley M, et al. Mortality in Rheumatoid Arthritis. Increased in the early course of disease, in Ischaemic Heart Disease and Pulmonary Fibrosis. Rheumatology (Oxford). 2007;46:350–357
  59. Reilly P, Cosh JA, Maddison PJ, et al. Mortality and survival in rheumatoid arthritis: a 25-year study of 100 patients. Ann Rheum Dis. 1990;49:363–369
  60. Goodson NJ, Wiles NJ, Lunt M, et al. Mortality in early inflammatory polyarthritis. Arthritis Rheum. 2002;2010–2019
  61. Mikuls TR, Saag KG, Criswell LA, et al. Mortality risk associated with rheumatoid arthritis in a prospective cohort of older women: results from the IOWA Women's Health Study. Ann Rheum Dis. 2002;61:994–999
  62. Ward M. Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs?. Arthritis Rheum. 2001;44:1467–1469
  63. Myllykangas-Luosujarvi R, Aho K, Isomaki H. Death attributed to anti-rheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol. 1995;22:2200–2202
  64. Bacon PA, Townsend JN. Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum. 2001;44:2707–2710
  65. Kitas GD, Erb N. Tackling ischaemic heart disease in rheumatoid arthritis. Rheumatology (Oxford). 2003;42:607–613
  66. Galindo-Rodriguez G, Avira Zubrieta J, Russell A, Suarez Almazor M. Disappointing long term results with disease modifying anti rheumatic drugs. A practice based study. J Rheumatol. 1999;16:237–243
  67. Krause D, Schleusser B, Herborn G, Rau R. Response to methotrexate treatment is associated with reduced mortality in patients with severe Rheumatoid Arthritis. Arthritis Rheum. 2000;43:14–21
  68. Pincus T, Callahan L. Taking mortality in rheumatoid arthritis seriously – predictive markers, socioeconomic status and comorbidity. J Rheumatol. 1986;13:841–845
  69. Pincus T, Gibofsky A, Weinblatt ME. Urgent care and tighter control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum. 2002;46:851–854
  70. Boers M, Dijkmans B, Gabriel S, et al. Making an impact on mortality in rheumatoid arthritis. Arthritis Rheum. 2004;50:1734–1739
  71. Young A, Koduri G. Extra-articular manifestations and complications of RA. Best Pract Res Clin Rheumatol. 2007;21:907–927
  72. Eberhardt K, Fex E. Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after five years. Br J Rheumatol. 1998;37:1324–1329
  73. Prevoo ML, van Gestel AM, van't Hof MA, et al. Remission in a prospective study of rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol. 1996;35:1101–1105
  74. Molenar ETH, Voskuyl AE, Dinant HJ, et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004;50:36–42
  75. Pincus T, Callahan LF. Prognostic markers of activity and damage in rheumatoid arthritis: why trials and inception cohort studies indicate more favourable outcomes than studies with more established disease. Br J Rheumatol. 1995;34:196–199

PII: S1521-6942(08)00156-3

doi: 10.1016/j.berh.2008.12.005

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 1 , Pages 3-12 , February 2009

Article Tools